Drug Report History
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.
| Version v8-FR | Version v1-EN | |
|---|---|---|
| Language | French | English |
| Date Updated | 2023-10-02 | 2022-05-18 |
| Drug Identification Number | 00568082 | 00568082 |
| Brand name | BSS PLUS | BSS PLUS |
| Common or Proper name | BSS PLUS NGP BAG | BSS PLUS NGP BAG |
| Company Name | ALCON CANADA INC | ALCON CANADA INC |
| Ingredients | GLUTATHIONE DISULFIDE DEXTROSE SODIUM BICARBONATE SODIUM PHOSPHATE DIBASIC MAGNESIUM CHLORIDE CALCIUM CHLORIDE POTASSIUM CHLORIDE SODIUM CHLORIDE | GLUTATHIONE DISULFIDE DEXTROSE SODIUM BICARBONATE SODIUM PHOSPHATE DIBASIC MAGNESIUM CHLORIDE CALCIUM CHLORIDE POTASSIUM CHLORIDE SODIUM CHLORIDE |
| Strength(s) | 0.0184% 0.092% 0.21% 0.042% 0.02% 0.0154% 0.038% 0.714% | 0.0184% 0.092% 0.21% 0.042% 0.02% 0.0154% 0.038% 0.714% |
| Dosage form(s) | KIT SOLUTION | KIT SOLUTION |
| Route of administration | INTRAOCULAR INTRAOCULAR | INTRAOCULAR INTRAOCULAR |
| Packaging size | 500ml | 500ml |
| ATC code | V07AB | V07AB |
| ATC description | ALL OTHER NON-THERAPEUTIC PRODUCTS | ALL OTHER NON-THERAPEUTIC PRODUCTS |
| Reason for shortage | Shortage of an active ingredient. | Shortage of an active ingredient. |
| Anticipated start date | 2022-05-18 | 2022-05-18 |
| Actual start date | 2022-05-18 | 2022-05-18 |
| Estimated end date | 2023-06-30 | 2022-07-01 |
| Actual end date | 2023-09-30 | |
| Shortage status | Resolved | Anticipated shortage |
| Tier 3 Status | No | No |
| Company comments | Estimated end date was updated for mid 2023 as shortages are ongoing, and inventory is being carefully managed | |
| Health Canada comments |